Synthetic Medicinal Chemistry in Chagas’ Disease: Compounds at The Final Stage of “Hit-To-Lead” Phase
Chagas’ disease, or American trypanosomosiasis, has been the most relevant illness produced by protozoa in Latin America. Synthetic medicinal chemistry efforts have provided an extensive number of chemodiverse hits at the “active-to-hit” stage. However, only a more limited number of these have been...
Main Authors: | Hugo Cerecetto, Mercedes González |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2010-03-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | http://www.mdpi.com/1424-8247/3/4/810/ |
Similar Items
-
Cheminformatic Profiling and Hit Prioritization of Natural Products with Activities against Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA)
by: Samson O. Oselusi, et al.
Published: (2021-06-01) -
Cheminformatic Characterization of Natural Antimicrobial Products for the Development of New Lead Compounds
by: Samson Olaitan Oselusi, et al.
Published: (2021-06-01) -
In Silico/In Vitro Hit-to-Lead Methodology Yields SMYD3 Inhibitor That Eliminates Unrestrained Proliferation of Breast Carcinoma Cells
by: Ilham M. Alshiraihi, et al.
Published: (2020-12-01) -
Prediction of Hit-to-Lead Ligand Molecule Interaction with G-Quadruplex DNA from c-Myc Oncogene Promoter Region
by: Petar M Mitrasinovic
Published: (2020-06-01) -
Drug therapy for double-hit lymphoma
by: Vania Phuoc, et al.
Published: (2019-12-01)